The multifunctional contribution of FGF signaling to cardiac development, homeostasis, disease and repair

F Khosravi, N Ahmadvand, S Bellusci… - Frontiers in cell and …, 2021 - frontiersin.org
The current focus on cardiovascular research reflects society's concerns regarding the
alarming incidence of cardiac-related diseases and mortality in the industrialized world and …

Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease

EM Onal, B Afsar, A Covic, ND Vaziri… - Hypertension Research, 2019 - nature.com
The health and proper functioning of the cardiovascular and renal systems largely depend
on crosstalk in the gut–kidney–heart/vessel triangle. Recent evidence suggests that the gut …

Клинические рекомендации ОССН-РКО-РНМОТ. Сердечная недостаточность: хроническая (ХСН) и острая декомпенсированная (ОДСН). Диагностика …

ВЮ Мареев, ИВ Фомин, ФТ Агеев, ЮЛ Беграмбекова… - Кардиология, 2018 - lib.ossn.ru
1–«МНОЦ МГУ им. МВ Ломоносова», 119192, Москва, Ломоносовский пр-кт, д. 27, корп.
10 2–ФГБОУ ВО «ПИМУ» МЗ РФ, 603950, Нижний Новгород, пл. Минина и Пожарского …

[HTML][HTML] Russian heart failure society, Russian society of cardiology. Russian scientific medical society of internal medicine guidelines for heart failure: chronic (CHF) …

VY Mareev, IV Fomin, FT Ageev, YL Begrambekova… - Kardiologiia, 2018 - lib.ossn.ru
РЕКОМЕНДАЦИИ, СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ, ХРОНИЧЕСКАЯ СЕРДЕЧНАЯ
НЕДОСТАТОЧНОСТЬ, ОСТРАЯ ДЕКОМПЕНСАЦИЯ СЕРДЕЧНОЙ …

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible

A Grabner, K Schramm, N Silswal, M Hendrix… - Scientific reports, 2017 - nature.com
Fibroblast growth factor (FGF) 23 is a phosphaturic hormone that directly targets cardiac
myocytes via FGF receptor (FGFR) 4 thereby inducing hypertrophic myocyte growth and the …

Cardiovascular impact in patients undergoing maintenance hemodialysis: clinical management considerations

S Chirakarnjanakorn, SD Navaneethan… - International journal of …, 2017 - Elsevier
Patients undergoing maintenance hemodialysis develop both structural and functional
cardiovascular abnormalities. Despite improvement of dialysis technology, cardiovascular …

Dapagliflozin protects heart function against type-4 cardiorenal syndrome through activation of PKM2/PP1/FUNDC1-dependent mitophagy

Y Shen, X Peng, H Ji, W Gong, H Zhu… - International Journal of …, 2023 - Elsevier
Dapagliflozin (DAPA) confers significant protection against heart and kidney diseases.
However, whether DAPA can alleviate type 4 cardiorenal syndrome (CRS-4)-related …

The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies

M Davies, S Chatterjee, K Khunti - … pharmacology: advances and …, 2016 - Taylor & Francis
Worldwide, an estimated 200 million people have chronic kidney disease (CKD), the most
common causes of which include hypertension, arteriosclerosis, and diabetes. Importantly …

Crucial role of the aryl hydrocarbon receptor (AhR) in indoxyl sulfate-induced vascular inflammation

S Ito, M Osaka, T Edamatsu, Y Itoh… - Journal of atherosclerosis …, 2016 - jstage.jst.go.jp
Aim: The aryl hydrocarbon receptor (AhR), a ligand-inducible transcription factor mediating
toxic effects of dioxins and uremic toxins, has recently emerged as a pathophysiological …

Oxidative stress: dual pathway induction in cardiorenal syndrome type 1 pathogenesis

GM Virzì, A Clementi, M De Cal… - Oxidative medicine …, 2015 - Wiley Online Library
Cardiorenal Syndrome Type 1 (Type 1) is a specific condition which is characterized by a
rapid worsening of cardiac function leading to acute kidney injury (AKI). Even though its …